SCHEMBL31545928

SCHEMBL31545928

CCCc1cc(O)c2c(c1)O[C@@H](C)CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 13/20 0.42
▸ CNR2 P34972 13/20 0.42
▸ TRPV1 Q8NER1 6/20 0.42
▸ TRPA1 O75762 3/20 0.42
▸ TRPV3 Q8NET8 3/20 0.42
▸ TRPV4 Q9HBA0 3/20 0.42
▸ TRPV2 Q9Y5S1 3/20 0.42
▸ TRPM8 Q7Z2W7 3/20 0.42
▸ GPR55 Q9Y2T6 3/20 0.42
▸ TRPV6 Q9H1D0 2/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ TRPV5 Q9NQA5 1/20 0.42
▸ CYP1A1 P04798 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2B6 P20813 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ OPRM1 P35372 1/20 0.39
▸ GPR6 P46095 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31545625 0.90 TRPV1 (0.50) CNR1CNR2TRPV1TRPM8GPR55
SCHEMBL31545281 0.90 TRPV1 (0.50) CNR1CNR2TRPV1TRPM8GPR55
SCHEMBL22942198 0.90 TRPV1 (0.50) CNR1CNR2TRPV1TRPM8GPR55
SCHEMBL23765233 0.73 CNR1 (0.46) CNR1CNR2TRPV1TRPA1TRPV3
SCHEMBL22058679 0.73 CNR1 (0.46) CNR1CNR2TRPV1TRPA1TRPV3
SCHEMBL31545815 0.71 OSBP (0.48) CNR1CNR2TRPV1TRPA1TRPV3
SCHEMBL17026873 0.71 OSBP (0.48) CNR1CNR2TRPV1TRPA1TRPV3
SCHEMBL24435736 0.69 TRPV1 (0.41) CNR1CNR2TRPV1TRPM8GPR55
SCHEMBL22739331 0.68 CNR1 (0.47) CNR1CNR2TRPV1TRPA1TRPV3
SCHEMBL14490157 0.68 DRD2 (0.41) HTR1ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 — — US disclosed
Send feedback